German committee rejects sildenafil OTC switch

27 January 2022 - Deborah Wilkes

Premium

Germany’s Expert Committee for Prescription has rejected an application to switch the erectile-dysfunction drug sildenafil from prescription to non-prescription status. The committee has also rejected a proposed switch for a combination medicine containing ipratropium bromide and xylometazoline.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: